Recent development in the discovery of PARP inhibitors as anticancer agents: a patent update (2016-2020).
Saved in:
| Title: | Recent development in the discovery of PARP inhibitors as anticancer agents: a patent update (2016-2020). |
|---|---|
| Authors: | Velagapudi UK; Pace Analytical Life Sciences, LLC, Suite 102, 19 Presidential Way, Woburn, MA, 01801, USA., Patel BA; Department of Chemistry and Biochemistry, The University of Notre Dame, 329 McCourtney Hall, Notre Dame, IN 46556, USA., Shao X; cFrontage Laboratories, Inc, 75 East Uwchlan Ave, Suite 100, Exton, PA, 19341, USA., Pathak SK; dChemistry and Biochemistry Department, Queens College of the City University of New York, 65-30 Kissena Blvd., Flushing, NY, 11367, USA.; eChemistry Doctoral Program, Biochemistry Doctoral Program, The Graduate Center of the City University of New York, 365 5th Ave, New York, NY, 10016, USA., Ferraris DV; fDepartment of Chemistry, McDaniel College, 2 College Hill, Westminster, MD, 21157, USA., Talele TT; gDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 11439, USA. |
| Source: | Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2021 Jul; Vol. 31 (7), pp. 609-623. Date of Electronic Publication: 2021 Mar 12. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 9516419 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7674 (Electronic) Linking ISSN: 13543776 NLM ISO Abbreviation: Expert Opin Ther Pat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
